Three Berkshire Hathaway Stocks Trading Well Below Highs

Berkshire Hathaway's investment strategy has long focused on acquiring stocks trading significantly below their intrinsic value, especially those with competitive advantages in mature industries. The company's portfolio, valued at approximately $350 billion, includes three notable holdings currently trading at least 15% below their highs: American Express, The New York Times Company, and DaVita.

American Express stands out as the sole remaining credit card stock in Berkshire's portfolio. The company has strengthened its position by increasing annual fees for its Platinum card to $895 and offering perks valued at $3,500. Despite a 18% drop in stock price this year, American Express reported a 10% increase in revenue and an 8% rise in net income for the second quarter.

The New York Times Company has defied industry trends by embracing digital media. With 13.35 million subscribers, mostly digital, the company saw an 11% revenue increase to $762.5 million in the second quarter. While print advertising continues to decline, digital ad revenue grew by 21%, contributing to a total ad revenue of $149 million.

DaVita, specializing in kidney disease treatment and dialysis services, is the only healthcare stock in Berkshire's portfolio. The company reported a 12% revenue increase to $3.55 billion and a 25% rise in net income for the second quarter. Despite a strong year with a 58% stock increase, DaVita remains 27% below its all-time high.